Development of an automated closed system for generation of human lymphokine-activated killer (LAK) cells for use in adoptive immunotherapy
Data up to Jan 2025
Total Citations Per Year
Abstract
References (11)
Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer
1985 • 2,616 citations
Important Advances in Oncology: 1986
1986 • 912 citations
Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2
1984 • 687 citations
Biological Activity of Recombinant Human Interleukin-2 Produced in Escherichia coli
1984 • 600 citations
Successful immunotherapy of murine experimental hepatic metastases with lymphokine-activated killer cells and recombinant interleukin 2.
1985 • 376 citations
The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo.
1985 • 293 citations
The adoptive immunotherapy of cancer using lymphokine activated killer cells and recombinant interleukin-2
1986 • 145 citations
Lysis of fresh human solid tumors by autologous lymphocytes activated in vitro with lectins.
1982 • 94 citations
Large scale production of human lymphokine activated killer cells for use in adoptive immunotherapy
1986 • 82 citations
An enzymatic method for the consistent production of monodispersed viable cell suspensions from human solid tumors
1985 • 27 citations
Morphological studies of peripheral monocytes during in vitro maturation by scanning electron microscopy
1982 • 5 citations
Cited By (0)
No citing papers found in database